Stories of Technology, Innovation, & Entrepreneurship in the Southeast

Frist Cressey Ventures (FCV), a Nashville-based health care investment firm, has announced the closing of its fourth fund at $425 million.

The fund exceeded initial fundraising goals, showing extreme confidence in FCV’s ability to predict the next generation of healthcare leaders. This is further supported by its history of 44 total investments and 14 successful exits.

“This milestone reflects the clarity of purpose, conviction and deep commitment of our team, investors and portfolio companies, all united by a shared mission to advance innovation in healthcare that improves lives and keeps patients at the center of everything we do,” said former Sen. Bill Frist, MD, Co-Founder and Managing Partner.

Relevance for early-stage companies

With the new capital, FCV plans to invest in early-stage companies that are rethinking the quality of care. This includes system integration, patient outcomes, affordability and access.

The strategic advantage

The fund’s investors include major health systems, national insurance providers like Cigna and more.

This backing is strategic. Instead of building your product or service in a silo, the selected startups are more likely to receive timely feedback and potential collaborations with the very hospitals and insurance companies they are looking to serve through the FCV Collective.

“Advancing a simpler, more connected health care experience requires a shared commitment to collaboration and continuous innovation across the industry,” said Craig Cimini, head of The Cigna Group Ventures. “Our collaboration with Frist Cressey will help advance solutions that drive better health outcomes, affordability, and experiences for the people we serve.”

Building the future of care delivery?

Connect with Frist Cressey Ventures to see how the fund can scale your healthcare business.

 

 

---